MAGRILAN

This brand name is authorized in Cyprus, Hong Kong SAR China, Lithuania, Malta, Romania, Singapore.

Active ingredients

The drug MAGRILAN contains one active pharmaceutical ingredient (API):

1
UNII I9W7N6B1KJ - FLUOXETINE HYDROCHLORIDE
 

Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors.

 
Read more about Fluoxetine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MAGRILAN Hard capsule MPI, EU: SmPC Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N06AB03 Fluoxetine N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
HK Department of Health Drug Office 35706
LT Valstybinė vaistų kontrolės tarnyba 1003503
MT Medicines Authority MA032/05301
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W08497001
SG Health Sciences Authority 05766P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.